momentum to the recent encouraging progress in new drug discovery and, as did the first asthma guidelines published 27 years ago, 14-17 lead to a decade or more of improved outcomes. We conclude the Commission with seven key recom mendations and summarise our views on how these could be developed to benefit patients with asthma (panel 1).
No takes yet. Share an insight, caveat, or question.
Pavord et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: